<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37256120</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Ras family signaling pathway in immunopathogenesis of inflammatory rheumatic diseases.</ArticleTitle><Pagination><StartPage>1151246</StartPage><MedlinePgn>1151246</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1151246</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1151246</ELocationID><Abstract><AbstractText>The Ras (rat sarcoma virus) is a GTP-binding protein that is considered one of the important members of the Ras-GTPase superfamily. The Ras involves several pathways in the cell that include proliferation, migration, survival, differentiation, and fibrosis. Abnormalities in the expression level and activation of the Ras family signaling pathway and its downstream kinases such as Raf/MEK/ERK1-2 contribute to the pathogenic mechanisms of rheumatic diseases including immune system dysregulation, inflammation, and fibrosis in systemic sclerosis (SSc); destruction and inflammation of synovial tissue in rheumatoid arthritis (RA); and autoantibody production and immune complexes formation in systemic lupus erythematosus (SLE); and enhance osteoblast differentiation and ossification during skeletal formation in ankylosing spondylitis (AS). In this review, the basic biology, signaling of Ras, and abnormalities in this pathway in rheumatic diseases including SSc, RA, AS, and SLE will be discussed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Sadeghi Shaker, Rokni, Mahmoudi and Farhadi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadeghi Shaker</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rokni</LastName><ForeName>Mohsen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmoudi</LastName><ForeName>Mahdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farhadi</LastName><ForeName>Elham</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013167" MajorTopicYN="Y">Spondylitis, Ankylosing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012213" MajorTopicYN="Y">Rheumatic Fever</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012595" MajorTopicYN="Y">Scleroderma, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ras signaling</Keyword><Keyword MajorTopicYN="N">ankylosing spondylitis</Keyword><Keyword MajorTopicYN="N">autoimmune inflammatory diseases</Keyword><Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">systemic sclerosis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>10</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37256120</ArticleId><ArticleId IdType="pmc">PMC10225558</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1151246</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wennerberg K, Rossman KL, Der CJ. The ras superfamily at a glance. J Cell Sci (2005) 118(5):843&#x2013;6. doi: 10.1242/jcs.01660</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01660</ArticleId><ArticleId IdType="pubmed">15731001</ArticleId></ArticleIdList></Reference><Reference><Citation>Longnecker DS, Terhune PG. What is the true rate of K-ras mutation in carcinoma of the pancreas? Pancreas (1998) 17(4):323&#x2013;4. doi: 10.1097/00006676-199811000-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006676-199811000-00001</ArticleId><ArticleId IdType="pubmed">9821172</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira JB, Bid&#xe8;re N, Niemela JE, Zheng L, Sakai K, Nix CP, et al. . NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci (2007) 104(21):8953&#x2013;8. doi: 10.1073/pnas.0702975104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0702975104</ArticleId><ArticleId IdType="pmc">PMC1885609</ArticleId><ArticleId IdType="pubmed">17517660</ArticleId></ArticleIdList></Reference><Reference><Citation>Smaldone S, Olivieri J, Gusella GL, Moroncini G, Gabrielli A, Ramirez F. Ha-ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. Fibrogenesis Tissue Repair (2011) 4(1):1&#x2013;10. doi: 10.1186/1755-1536-4-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-1536-4-8</ArticleId><ArticleId IdType="pmc">PMC3059295</ArticleId><ArticleId IdType="pubmed">21362163</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K, Deshpande P, Pryshchep S, Colmegna I, Liarski V, Weyand CM, et al. . ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis. J Immunol (2009) 183(12):8258&#x2013;67. doi: 10.4049/jimmunol.0901784</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901784</ArticleId><ArticleId IdType="pmc">PMC2828269</ArticleId><ArticleId IdType="pubmed">20007589</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorelik G, Richardson B. Key role of ERK pathway signaling in lupus. Autoimmunity (2010) 43(1):17&#x2013;22. doi: 10.3109/08916930903374832</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916930903374832</ArticleId><ArticleId IdType="pmc">PMC2819407</ArticleId><ArticleId IdType="pubmed">19961364</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennanen P, Kallionp&#xe4;&#xe4; RA, Peltonen S, Nissinen L, K&#xe4;h&#xe4;ri VM, Heerv&#xe4; E, et al. . Signaling pathways in human osteoclasts differentiation: ERK1/2 as a key player. Mol Biol Rep (2021) 48(2):1243&#x2013;54. doi: 10.1007/s11033-020-06128-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-06128-5</ArticleId><ArticleId IdType="pmc">PMC7925492</ArticleId><ArticleId IdType="pubmed">33486672</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng G, Xie Z, Wang P, Li J, Li M, Cen S, et al. . Enhanced osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis: a study based on a three-dimensional biomimetic environment. Cell Death Dis (2019) 10(5):350. doi: 10.1038/s41419-019-1586-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1586-1</ArticleId><ArticleId IdType="pmc">PMC6484086</ArticleId><ArticleId IdType="pubmed">31024000</ArticleId></ArticleIdList></Reference><Reference><Citation>Papaioannou G, Mirzamohammadi F, Kobayashi T. Ras signaling regulates osteoprogenitor cell proliferation and bone formation. Cell Death Dis (2016) 7(10):e2405. doi: 10.1038/cddis.2016.314</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2016.314</ArticleId><ArticleId IdType="pmc">PMC5133981</ArticleId><ArticleId IdType="pubmed">27735946</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann C. Ras&#x2013;effector interactions: after one decade. Curr Opin Struct Biol (2003) 13(1):122&#x2013;9. doi: 10.1016/S0959-440X(02)00007-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-440X(02)00007-6</ArticleId><ArticleId IdType="pubmed">12581669</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruta H. PAKs, RAC/CDC42 (p21)-activated kinases: towards the cure of cancer and other PAK-dependent diseases: newnes. Melbourne, Australia: Elsevier; (2013).</Citation></Reference><Reference><Citation>Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF. Activation of raf as a result of recruitment to the plasma membrane. Science (1994) 264(5164):1463&#x2013;7. doi: 10.1126/science.7811320</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7811320</ArticleId><ArticleId IdType="pubmed">7811320</ArticleId></ArticleIdList></Reference><Reference><Citation>Leevers SJ, Paterson HF, Marshall CJ. Requirement for ras in raf activation is overcome by targeting raf to the plasma membrane. Nature (1994) 369(6479):411&#x2013;4. doi: 10.1038/369411a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/369411a0</ArticleId><ArticleId IdType="pubmed">8196769</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi-Far R, Campbell S, Rossman KL, Der CJ. Increasing complexity of ras signal transduction: involvement of rho family proteins. Adv Cancer Res (1997) 72:57&#x2013;107. doi: 10.1016/S0065-230X(08)60700-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-230X(08)60700-9</ArticleId><ArticleId IdType="pubmed">9338074</ArticleId></ArticleIdList></Reference><Reference><Citation>Rokni M, Sadeghi Shaker M, Kavosi H, Shokoofi S, Mahmoudi M, Farhadi E. The role of endothelin and RAS/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications. Arthritis Res Ther (2022) 24(1):108. doi: 10.1186/s13075-022-02787-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-022-02787-w</ArticleId><ArticleId IdType="pmc">PMC9102675</ArticleId><ArticleId IdType="pubmed">35562771</ArticleId></ArticleIdList></Reference><Reference><Citation>Reedquist KA, Tak PP. Suppl 2: signal transduction pathways in chronic inflammatory autoimmune disease: small GTPases. Open Rheumatol J (2012) 6:259. doi: 10.2174/1874312901206010259</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874312901206010259</ArticleId><ArticleId IdType="pmc">PMC3460313</ArticleId><ArticleId IdType="pubmed">23028410</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CL, Kikuchi K, Kondo M. Activation of mitogen-activated protein kinase kinase (MEK)/extracellular signal regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment. Blood (2007) 110(5):1420&#x2013;8. doi: 10.1182/blood-2007-02-071761</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-02-071761</ArticleId><ArticleId IdType="pmc">PMC1975832</ArticleId><ArticleId IdType="pubmed">17536016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma WT, Gao F, Gu K, Chen DK. The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front Immunol (2019) 10:1140. doi: 10.3389/fimmu.2019.01140</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01140</ArticleId><ArticleId IdType="pmc">PMC6543461</ArticleId><ArticleId IdType="pubmed">31178867</ArticleId></ArticleIdList></Reference><Reference><Citation>Navegantes KC, de Souza Gomes R, Pereira PAT, Czaikoski PG, Azevedo CHM, Monteiro MC. Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity. J Trans Med (2017) 15(1):36. doi: 10.1186/s12967-017-1141-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1141-8</ArticleId><ArticleId IdType="pmc">PMC5312441</ArticleId><ArticleId IdType="pubmed">28202039</ArticleId></ArticleIdList></Reference><Reference><Citation>Malyshev I, Malyshev Y. Current concept and update of the macrophage plasticity concept: intracellular mechanisms of reprogramming and M3 macrophage "Switch" phenotype. BioMed Res Int (2015) 2015:341308. doi: 10.1155/2015/341308</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/341308</ArticleId><ArticleId IdType="pmc">PMC4561113</ArticleId><ArticleId IdType="pubmed">26366410</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Jhong JH, Chen Q, Huang KY, Strittmatter K, Kreuzer J, et al. . Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors. Cell Rep (2021) 37(5):109955. doi: 10.1016/j.celrep.2021.109955</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109955</ArticleId><ArticleId IdType="pmc">PMC8783961</ArticleId><ArticleId IdType="pubmed">34731634</ArticleId></ArticleIdList></Reference><Reference><Citation>Riegel K, Rajalingam K. The non-linearity of RAF-MEK signaling in dendritic cells. Cell Cycle (Georgetown Tex) (2020) 19(18):2249&#x2013;59. doi: 10.1080/15384101.2020.1795990</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2020.1795990</ArticleId><ArticleId IdType="pmc">PMC7513879</ArticleId><ArticleId IdType="pubmed">32752922</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Laar L, Coffer PJ, Woltman AM. Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy. Blood (2012) 119(15):3383&#x2013;93. doi: 10.1182/blood-2011-11-370130</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-11-370130</ArticleId><ArticleId IdType="pubmed">22323450</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray A, Basu S, Miller NM, Chan AM, Dittel BN. An increase in tolerogenic dendritic cell and natural regulatory T cell numbers during experimental autoimmune encephalomyelitis in rras&#x2013;/&#x2013; mice results in attenuated disease. J Immunol (2014) 192(11):5109&#x2013;17. doi: 10.4049/jimmunol.1302254</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302254</ArticleId><ArticleId IdType="pmc">PMC4041102</ArticleId><ArticleId IdType="pubmed">24771856</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh G, Hashimoto D, Yan X, Helft J, Park PJ, Ma G, et al. . R-ras is required for murine dendritic cell maturation and CD4+ T-cell priming. Blood (2012) 119(7):1693&#x2013;701. doi: 10.1182/blood-2011-05-357319</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-05-357319</ArticleId><ArticleId IdType="pmc">PMC3286347</ArticleId><ArticleId IdType="pubmed">22174156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwabara T, Matsui Y, Ishikawa F, Kondo M. Regulation of T-cell signaling by post-translational modifications in autoimmune disease. Int J Mol Sci (2018) 19(3):819. doi: 10.3390/ijms19030819</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19030819</ArticleId><ArticleId IdType="pmc">PMC5877680</ArticleId><ArticleId IdType="pubmed">29534522</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeil LK, Starr TK, Hogquist KA. A requirement for sustained ERK signaling during thymocyte positive selection in vivo. Proc Natl Acad Sci (2005) 102(38):13574&#x2013;9. doi: 10.1073/pnas.0505110102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0505110102</ArticleId><ArticleId IdType="pmc">PMC1224638</ArticleId><ArticleId IdType="pubmed">16174747</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelli MP, Lin H, Zhang W, Samelson LE, Bierer BE. Signaling via LAT (linker for T-cell activation) and Syk/ZAP70 is required for ERK activation and NFAT transcriptional activation following CD2 stimulation. Blood J Am Soc Hematol (2000) 96(6):2181&#x2013;90. doi: 10.1182/blood.V96.6.2181</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V96.6.2181</ArticleId><ArticleId IdType="pubmed">10979964</ArticleId></ArticleIdList></Reference><Reference><Citation>So E-Y, Oh J, Jang J-Y, Kim J-H, Lee C-E. Ras/Erk pathway positively regulates Jak1/STAT6 activity and IL-4 gene expression in jurkat T cells. Mol Immunol (2007) 44(13):3416&#x2013;26. doi: 10.1016/j.molimm.2007.02.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2007.02.022</ArticleId><ArticleId IdType="pubmed">17433443</ArticleId></ArticleIdList></Reference><Reference><Citation>Baars MJ, Douma T, Simeonov DR, Myers DR, Kulhanek K, Banerjee S, et al. . Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity. Eur J Immunol (2021) 51(2):471&#x2013;82. doi: 10.1002/eji.201948451</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201948451</ArticleId><ArticleId IdType="pmc">PMC7894479</ArticleId><ArticleId IdType="pubmed">33065764</ArticleId></ArticleIdList></Reference><Reference><Citation>Donahue AC, Fruman DA. Distinct signaling mechanisms activate the target of rapamycin in response to different b-cell stimuli. Eur J Immunol (2007) 37(10):2923&#x2013;36. doi: 10.1002/eji.200737281</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200737281</ArticleId><ArticleId IdType="pubmed">17724683</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivieri J, Coluzzi S, Attolico I, Olivieri A. Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside. TheScientific World J (2011) 11:1908&#x2013;31. doi: 10.1100/2011/924954</Citation><ArticleIdList><ArticleId IdType="doi">10.1100/2011/924954</ArticleId><ArticleId IdType="pmc">PMC3217614</ArticleId><ArticleId IdType="pubmed">22125447</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzyzowska M, Swiatek W, Fijalkowska B, Niemialtowski M, Schollenberger A. The role of MAP kinases in immune response. Adv Cell Biol (2010) 2:125&#x2013;38. doi: 10.2478/v10052-010-0007-5</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/v10052-010-0007-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Teodorovic LS, Babolin C, Rowland SL, Greaves SA, Baldwin DP, Torres RM, et al. . Activation of ras overcomes b-cell tolerance to promote differentiation of autoreactive b cells and production of autoantibodies. Proc Natl Acad Sci (2014) 111(27):E2797&#x2013;E806. doi: 10.1073/pnas.1402159111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1402159111</ArticleId><ArticleId IdType="pmc">PMC4103347</ArticleId><ArticleId IdType="pubmed">24958853</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng G-M, Kyttaris VC, Tsokos GC. Targeting syk in autoimmune rheumatic diseases. Front Immunol (2016) 7. doi: 10.3389/fimmu.2016.00078</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00078</ArticleId><ArticleId IdType="pmc">PMC4779881</ArticleId><ArticleId IdType="pubmed">27014261</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaves SA, Peterson JN, Torres RM, Pelanda R. Activation of the MEK-ERK pathway is necessary but not sufficient for breaking central b cell tolerance. Front Immunol (2018) 9:707. doi: 10.3389/fimmu.2018.00707</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00707</ArticleId><ArticleId IdType="pmc">PMC5900439</ArticleId><ArticleId IdType="pubmed">29686680</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Inamine A, Hashimoto S, Haraguchi S, Yoshioka E, Kojima N, et al. . Novel role of the ras cascade in memory b cell response. Immunity (2005) 23(2):127&#x2013;38. doi: 10.1016/j.immuni.2005.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2005.06.010</ArticleId><ArticleId IdType="pubmed">16111632</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanshylla K, Bartsch C, Hitzing C, Kr&#xfc;mpelmann L, Wienands J, Engels N. Grb2 and GRAP connect the b cell antigen receptor to erk MAP kinase activation in human b cells. Sci Rep (2018) 8(1):4244. doi: 10.1038/s41598-018-22544-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22544-x</ArticleId><ArticleId IdType="pmc">PMC5844867</ArticleId><ArticleId IdType="pubmed">29523808</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin JJ, Stang SL, Dower NA, Stone JC. RasGRP1 and RasGRP3 regulate b cell proliferation by facilitating b cell receptor-ras signaling. J Immunol (2005) 175(11):7179&#x2013;84. doi: 10.4049/jimmunol.175.11.7179</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.11.7179</ArticleId><ArticleId IdType="pubmed">16301621</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes-Calvo I, Bl&#xe1;zquez-Medela AM, Eleno N, Santos E, L&#xf3;pez-Novoa JM, Mart&#xed;nez-Salgado C. H-ras isoform modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts. Am J Physiology-Cell Physiol (2012) 302(4):C686&#x2013;C97. doi: 10.1152/ajpcell.00103.2011</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00103.2011</ArticleId><ArticleId IdType="pubmed">22094331</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Novoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med (2009) 1(6-7):303&#x2013;14. doi: 10.1002/emmm.200900043</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.200900043</ArticleId><ArticleId IdType="pmc">PMC3378143</ArticleId><ArticleId IdType="pubmed">20049734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Choi JA, Kim JH. Ras promotes transforming growth factor-&#x3b2; (TGF-&#x3b2;)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells. J Biol Chem (2014) 289(32):22151&#x2013;60. doi: 10.1074/jbc.M114.556126</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.556126</ArticleId><ArticleId IdType="pmc">PMC4139228</ArticleId><ArticleId IdType="pubmed">24990945</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe CC, Dockrell ME, Noor MI, Monia BP, Hendry BM. Role of ras isoforms in the stimulated proliferation of human renal fibroblasts in primary culture. J Am Soc Nephrology (2000) 11(9):1600&#x2013;6. doi: 10.1681/ASN.V1191600</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.V1191600</ArticleId><ArticleId IdType="pubmed">10966484</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi K, Garg M. Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer. J Cell Communication Signaling (2018) 12(3):513&#x2013;27. doi: 10.1007/s12079-017-0441-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12079-017-0441-3</ArticleId><ArticleId IdType="pmc">PMC6039341</ArticleId><ArticleId IdType="pubmed">29330773</ArticleId></ArticleIdList></Reference><Reference><Citation>Santamaria PG, Nebreda AR. Deconstructing ERK signaling in tumorigenesis. Mol Cell (2010) 38(1):3&#x2013;5. doi: 10.1016/j.molcel.2010.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.03.012</ArticleId><ArticleId IdType="pubmed">20385084</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, et al. . Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of e-cadherin. J Cell Biochem (2011) 112(9):2508&#x2013;17. doi: 10.1002/jcb.23175</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.23175</ArticleId><ArticleId IdType="pubmed">21557297</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiery JP. Cell adhesion in development: a complex signaling network. Curr Opin Genet Dev (2003) 13(4):365&#x2013;71. doi: 10.1016/S0959-437X(03)00088-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-437X(03)00088-1</ArticleId><ArticleId IdType="pubmed">12888009</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnson KW, Almadani Y, Philip A. Non-canonical (non-SMAD2/3) TGF-&#x3b2; signaling in fibrosis: mechanisms and targets. In seminars in cell &amp; developmental biology. Academic Press. (2020) 101:115&#x2013;122</Citation><ArticleIdList><ArticleId IdType="pubmed">31883994</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins SP, Tang Y, Higgins CE, Mian B, Zhang W, Czekay R-P, et al. . TGF-&#x3b2;1/p53 signaling in renal fibrogenesis. Cell Signalling (2018) 43:1&#x2013;10. doi: 10.1016/j.cellsig.2017.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2017.11.005</ArticleId><ArticleId IdType="pmc">PMC5860677</ArticleId><ArticleId IdType="pubmed">29191563</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich N, Maurer B, Akhmetshina A, Venalis P, Dees C, Zerr P, et al. . The transcription factor fra-2 regulates the production of extracellular matrix in systemic sclerosis. Arthritis Rheumatism: Off J Am Coll Rheumatol (2010) 62(1):280&#x2013;90. doi: 10.1002/art.25056</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.25056</ArticleId><ArticleId IdType="pubmed">20039427</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielli A, Svegliati S, Moroncini G, Amico D. Suppl 1: new insights into the role of oxidative stress in scleroderma fibrosis. Open Rheumatol J (2012) 6:87. doi: 10.2174/1874312901206010087</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874312901206010087</ArticleId><ArticleId IdType="pmc">PMC3395898</ArticleId><ArticleId IdType="pubmed">22802906</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter K, Kietzmann T. Reactive oxygen species and fibrosis: further evidence of a significant liaison. Cell Tissue Res (2016) 365(3):591&#x2013;605. doi: 10.1007/s00441-016-2445-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-016-2445-3</ArticleId><ArticleId IdType="pmc">PMC5010605</ArticleId><ArticleId IdType="pubmed">27345301</ArticleId></ArticleIdList></Reference><Reference><Citation>Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, Walian PJ, et al. . Isoform-specific activation of latent transforming growth factor &#x3b2; (LTGF-&#x3b2;) by reactive oxygen species. Radiat Res (2006) 166(6):839&#x2013;48. doi: 10.1667/RR0695.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1667/RR0695.1</ArticleId><ArticleId IdType="pubmed">17149983</ArticleId></ArticleIdList></Reference><Reference><Citation>Dosoki H. The role of NADPH oxidase in the pathogenesis of systemic sclerosis. M&#xfc;nster, Germany: Universit&#xe4;ts-und Landesbibliothek M&#xfc;nster; (2016).</Citation></Reference><Reference><Citation>Piera-Velazquez S, Jimenez SA. Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis. Curr Rheumatol Rep (2015) 17(1):1&#x2013;11. doi: 10.1007/s11926-014-0473-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-014-0473-0</ArticleId><ArticleId IdType="pmc">PMC6779060</ArticleId><ArticleId IdType="pubmed">25475596</ArticleId></ArticleIdList></Reference><Reference><Citation>Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G, et al. . Platelet-derived growth factor and reactive oxygen species (ROS) regulate ras protein levels in primary human fibroblasts via ERK1/2: amplification of ROS and ras in systemic sclerosis fibroblasts. J Biol Chem (2005) 280(43):36474&#x2013;82. doi: 10.1074/jbc.M502851200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M502851200</ArticleId><ArticleId IdType="pubmed">16081426</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M, Kim M, Suh Y, Kim R, Kim H, Lim E, et al. . Novel signaling axis for ROS generation during K-ras-induced cellular transformation. Cell Death Differentiation (2014) 21(8):1185&#x2013;97. doi: 10.1038/cdd.2014.34</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.34</ArticleId><ArticleId IdType="pmc">PMC4085525</ArticleId><ArticleId IdType="pubmed">24632950</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev (2008) 22(10):1276&#x2013;312. doi: 10.1101/gad.1653708</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1653708</ArticleId><ArticleId IdType="pmc">PMC2732412</ArticleId><ArticleId IdType="pubmed">18483217</ArticleId></ArticleIdList></Reference><Reference><Citation>Svegliati Baroni S, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, et al. . Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. New Engl J Med (2006) 354(25):2667&#x2013;76. doi: 10.1056/NEJMoa052955</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa052955</ArticleId><ArticleId IdType="pubmed">16790699</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth factor Rev (2004) 15(4):255&#x2013;73. doi: 10.1016/j.cytogfr.2004.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2004.03.006</ArticleId><ArticleId IdType="pubmed">15207816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancrile BB, O'Hayer KM, Counter CM. Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics. Mol Interventions (2008) 8(1):22&#x2013;7. doi: 10.1124/mi.8.1.6</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mi.8.1.6</ArticleId><ArticleId IdType="pmc">PMC2788125</ArticleId><ArticleId IdType="pubmed">18332481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F, Zhu Y, Hu G. Naringin promotes cellular chemokine synthesis and potentiates mesenchymal stromal cell migration via the ras signaling pathway. Exp Ther Med (2018) 16(4):3504&#x2013;10. doi: 10.3892/etm.2018.6634</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6634</ArticleId><ArticleId IdType="pmc">PMC6143896</ArticleId><ArticleId IdType="pubmed">30233702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayoud M, Marcu-Malina V, Vax E, Jacob-Hirsch J, Elad-Sfadia G, Barshack I, et al. . Ras signaling inhibitors attenuate disease in adjuvant-induced arthritis via targeting pathogenic antigen-specific Th17-type cells. Front Immunol (2017) 8:799. doi: 10.3389/fimmu.2017.00799</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00799</ArticleId><ArticleId IdType="pmc">PMC5500629</ArticleId><ArticleId IdType="pubmed">28736556</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii H. Mechanisms of signal transduction from receptors of type I and type II cytokines. J immunotoxicology (2007) 4(1):69&#x2013;76. doi: 10.1080/15476910601154779</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476910601154779</ArticleId><ArticleId IdType="pubmed">18958714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinbara K, Goldfinger LE, Hansen M, Chou FL, Ginsberg MH. Ras GTPases: integrins' friends or foes? Nat Rev Mol Cell Biol (2003) 4(10):767&#x2013;76. doi: 10.1038/nrm1229</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1229</ArticleId><ArticleId IdType="pubmed">14570053</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu XS, Vanderziel C, Bennett CF, Monia BP. A role for c-raf kinase and ha-ras in cytokine-mediated induction of cell adhesion molecules. J Biol Chem (1998) 273(50):33230&#x2013;8. doi: 10.1074/jbc.273.50.33230</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.50.33230</ArticleId><ArticleId IdType="pubmed">9837893</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K, Chung YH, Ahn H, Kim H, Rho J, Jeong D. Selective regulation of MAPK signaling mediates RANKL-dependent osteoclast differentiation. Int J Biol Sci (2016) 12(2):235. doi: 10.7150/ijbs.13814</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.13814</ArticleId><ArticleId IdType="pmc">PMC4737679</ArticleId><ArticleId IdType="pubmed">26884720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K, Seo I, Choi MH, Jeong D. Roles of mitogen-activated protein kinases in osteoclast biology. Int J Mol Sci (2018) 19(10):3004. doi: 10.3390/ijms19103004</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19103004</ArticleId><ArticleId IdType="pmc">PMC6213329</ArticleId><ArticleId IdType="pubmed">30275408</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang B, Yuan C, Han J, Shen M, Zhou X, Zhou L. miR-143-3p inhibits the differentiation of osteoclast induced by synovial fibroblast and monocyte coculture in adjuvant-induced arthritic rats. BioMed Res Int (2021) 2021. doi: 10.1155/2021/5565973</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5565973</ArticleId><ArticleId IdType="pmc">PMC8416385</ArticleId><ArticleId IdType="pubmed">34485516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Kim HS, Yeon J-T, Choi S-W, Chun CH, Kwak HB, et al. . GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway. J Immunol (2009) 183(5):3390&#x2013;9. doi: 10.4049/jimmunol.0804314</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0804314</ArticleId><ArticleId IdType="pubmed">19641137</ArticleId></ArticleIdList></Reference><Reference><Citation>Weivoda MM, Oursler MJ. The roles of small GTPases in osteoclast biology. Orthopedic muscular system Curr Res (2014) 3. doi: 10.4172/2161-0533.1000161</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2161-0533.1000161</ArticleId><ArticleId IdType="pmc">PMC4296324</ArticleId><ArticleId IdType="pubmed">25599004</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindeler A, Little DG. Ras-MAPK signaling in osteogenic differentiation: friend or foe? J Bone mineral Res Off J Am Soc Bone Mineral Res (2006) 21(9):1331&#x2013;8. doi: 10.1359/jbmr.060603</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.060603</ArticleId><ArticleId IdType="pubmed">16939391</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med (2009) 360(19):1989&#x2013;2003. doi: 10.1056/NEJMra0806188</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0806188</ArticleId><ArticleId IdType="pubmed">19420368</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierra-Sep&#xfa;lveda A, Esquinca-Gonz&#xe1;lez A, Benavides-Su&#xe1;rez SA, Sordo-Lima DE, Caballero-Islas AE, Cabral-Casta&#xf1;eda AR, et al. . Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast. BioMed Res Int (2019) 2019. doi: 10.1155/2019/4569826</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4569826</ArticleId><ArticleId IdType="pmc">PMC6364098</ArticleId><ArticleId IdType="pubmed">30809542</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone J. C.. Regulation of Ras in lymphocytes: get a GRP. Biochem Soc Trans (2006) 34(5):858&#x2013;61. doi: 10.1042/BST0340858</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0340858</ArticleId><ArticleId IdType="pubmed">17052215</ArticleId></ArticleIdList></Reference><Reference><Citation>Roumm AD, Whiteside TL, Medsger TA, Jr., Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis. Arthritis Rheumatism: Off J Am Coll Rheumatol (1984) 27(6):645&#x2013;53. doi: 10.1002/art.1780270607</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780270607</ArticleId><ArticleId IdType="pubmed">6375682</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi J-T, Pergamenschikov A, et al. . Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci (2003) 100(21):12319&#x2013;24. doi: 10.1073/pnas.1635114100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1635114100</ArticleId><ArticleId IdType="pmc">PMC218756</ArticleId><ArticleId IdType="pubmed">14530402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner H, Shearstone JR, Bandaru R, Crowell T, Lynes M, Trojanowska M, et al. . Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. Arthritis Rheumatism (2006) 54(6):1961&#x2013;73. doi: 10.1002/art.21894</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21894</ArticleId><ArticleId IdType="pubmed">16736506</ArticleId></ArticleIdList></Reference><Reference><Citation>Meloni F, Solari N, Cavagna L, Morosini M, Montecucco CM, Fietta AM. Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. Clin Exp Rheumatol (2009) 27(5):765.</Citation><ArticleIdList><ArticleId IdType="pubmed">19917158</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakkas LI, Platsoucas CD. Is systemic sclerosis an antigen-driven T cell disease? Arthritis Rheumatism: Off J Am Coll Rheumatol (2004) 50(6):1721&#x2013;33. doi: 10.1002/art.20315</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20315</ArticleId><ArticleId IdType="pubmed">15188347</ArticleId></ArticleIdList></Reference><Reference><Citation>Chizzolini C, Parel Y, De Luca C, Tyndall A, &#xc5;kesson A, Scheja A, et al. . Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor &#x3b1;. Arthritis Rheumatism: Off J Am Coll Rheumatol (2003) 48(9):2593&#x2013;604. doi: 10.1002/art.11129</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.11129</ArticleId><ArticleId IdType="pubmed">13130479</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavalia C, Scaletti C, Romagnani P, Carossino AM, Pignone A, Emmi L, et al. . Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol (1997) 151(6):1751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1858349</ArticleId><ArticleId IdType="pubmed">9403725</ArticleId></ArticleIdList></Reference><Reference><Citation>O'reilly S, Cant R, Ciechomska M, Van Laar JM. Interleukin-6: a new therapeutic target in systemic sclerosis? Clin Trans Immunol (2013) 2(4):e4. doi: 10.1038/cti.2013.2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2013.2</ArticleId><ArticleId IdType="pmc">PMC4232056</ArticleId><ArticleId IdType="pubmed">25505952</ArticleId></ArticleIdList></Reference><Reference><Citation>Mel&#xe9;ndez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension (2010) 56(2):225&#x2013;31. doi: 10.1161/HYPERTENSIONAHA.109.148635</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.109.148635</ArticleId><ArticleId IdType="pmc">PMC2921860</ArticleId><ArticleId IdType="pubmed">20606113</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao F, Liu Q, Zhu Y, Fan Z, Chen W, Liu S, et al. . Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis. Nat Commun (2021) 12(1):6540. doi: 10.1038/s41467-021-26750-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26750-6</ArticleId><ArticleId IdType="pmc">PMC8585952</ArticleId><ArticleId IdType="pubmed">34764263</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Li YG, Li YH, Qi L, Liu XG, Yuan CZ, et al. . Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PloS One (2012) 7(4):e31000. doi: 10.1371/journal.pone.0031000</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0031000</ArticleId><ArticleId IdType="pmc">PMC3317658</ArticleId><ArticleId IdType="pubmed">22485125</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt VE, Luo Y, Colbert RA. IL-22 effects on osteoblast mineralization and metabolic profile. J Immunol (2020) 204(1 Supplement):73.7&#x2013;.7. doi: 10.4049/jimmunol.204.Supp.73.7</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.204.Supp.73.7</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang P, Xie Z, Huang L, Yang R, Gao L, et al. . Whole genome expression profiling and signal pathway screening of MSCs in ankylosing spondylitis. Stem Cells Int (2014) 2014:913050. doi: 10.1155/2014/913050</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/913050</ArticleId><ArticleId IdType="pmc">PMC4269092</ArticleId><ArticleId IdType="pubmed">25544849</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe-Takano H, Takano K, Keduka E, Endo T. M-ras is activated by bone morphogenetic protein-2 and participates in osteoblastic determination, differentiation, and transdifferentiation. Exp Cell Res (2010) 316(3):477&#x2013;90. doi: 10.1016/j.yexcr.2009.09.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2009.09.028</ArticleId><ArticleId IdType="pubmed">19800879</ArticleId></ArticleIdList></Reference><Reference><Citation>Young LC, Rodriguez-Viciana P. MRAS: a close but understudied member of the RAS family. Cold Spring Harbor Perspect Med (2018) 8(12):a033621. doi: 10.1101/cshperspect.a033621</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a033621</ArticleId><ArticleId IdType="pmc">PMC6280710</ArticleId><ArticleId IdType="pubmed">29311130</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho ML, Yoon CH, Hwang SY, Park MK, Min SY, Lee SH, et al. . Effector function of type II collagen&#x2013;stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. Arthritis Rheumatism (2004) 50(3):776&#x2013;84. doi: 10.1002/art.20106</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20106</ArticleId><ArticleId IdType="pubmed">15022319</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Reprint&#x2013;preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther (2009) 89(9):873&#x2013;80. doi: 10.1093/ptj/89.9.873</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/89.9.873</ArticleId><ArticleId IdType="pubmed">19723669</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-&#x3b1; production in rheumatoid arthritis. Nat Med (1997) 3(2):189&#x2013;95. doi: 10.1038/nm0297-189</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0297-189</ArticleId><ArticleId IdType="pubmed">9018238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, et al. . Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheumatism: Off J Am Coll Rheumatol (2001) 44(5):1003&#x2013;12. doi: 10.1002/1529-0131(200105)44:5&lt;1003::AID-ANR179&gt;3.0.CO;2-#</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200105)44:5&lt;1003::AID-ANR179&gt;3.0.CO;2-#</ArticleId><ArticleId IdType="pubmed">11352231</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HR, Kim KW, Kim BM, Jung HG, Cho ML, Lee SH. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell&#x2013;derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Arthritis Rheumatol (2014) 66(3):538&#x2013;48. doi: 10.1002/art.38286</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38286</ArticleId><ArticleId IdType="pubmed">24574213</ArticleId></ArticleIdList></Reference><Reference><Citation>Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. . T Cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 183(6):2593&#x2013;603. doi: 10.1084/jem.183.6.2593</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.183.6.2593</ArticleId><ArticleId IdType="pmc">PMC2192621</ArticleId><ArticleId IdType="pubmed">8676080</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Wang JC, Liang TH, Zhu MH, Wang JY, Fu XL, et al. . Pathologic finding of increased expression of interleukin-17 in the synovial tissue of rheumatoid arthritis patients. Int J Clin Exp Pathol (2013) 6(7):1375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3693203</ArticleId><ArticleId IdType="pubmed">23826419</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K, Deshpande P, Li G, Yu M, Pryshchep S, Cavanagh M, et al. . K-RAS GTPase- and b-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis. Proc Natl Acad Sci USA (2012) 109(25):E1629&#x2013;37. doi: 10.1073/pnas.1117640109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1117640109</ArticleId><ArticleId IdType="pmc">PMC3382540</ArticleId><ArticleId IdType="pubmed">22615393</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev (2010) 233(1):233&#x2013;55. doi: 10.1111/j.0105-2896.2009.00859.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2009.00859.x</ArticleId><ArticleId IdType="pmc">PMC2913689</ArticleId><ArticleId IdType="pubmed">20193003</ArticleId></ArticleIdList></Reference><Reference><Citation>Abeles AM, Marjanovic N, Park J, Attur M, Chan ES, Al-Mussawir HE, et al. . Protein isoprenylation regulates secretion of matrix metalloproteinase 1 from rheumatoid synovial fibroblasts: effects of statins and farnesyl and geranylgeranyl transferase inhibitors. Arthritis Rheumatism: Off J Am Coll Rheumatol (2007) 56(9):2840&#x2013;53. doi: 10.1002/art.22824</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22824</ArticleId><ArticleId IdType="pubmed">17763406</ArticleId></ArticleIdList></Reference><Reference><Citation>Abreu JR, de Launay D, Sanders ME, Grabiec AM, van de Sande MG, Tak PP, et al. . The ras guanine nucleotide exchange factor RasGRF1 promotes matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue. Arthritis Res Ther (2009) 11(4):1&#x2013;13. doi: 10.1186/ar2785</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2785</ArticleId><ArticleId IdType="pmc">PMC2745805</ArticleId><ArticleId IdType="pubmed">19678938</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto A, Fukuda A, Seto H, Miyazaki T, Kadono Y, Sawada Y, et al. . Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative ras gene transfer to synoviocytes and osteoclasts. Arthritis Rheumatism: Off J Am Coll Rheumatol (2003) 48(9):2682&#x2013;92. doi: 10.1002/art.11214</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.11214</ArticleId><ArticleId IdType="pubmed">13130489</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Liu J, Zhang M, Wei S, Li R, Gao Y, et al. . Apoptosis induction of fibroblast-like synoviocytes is an important molecular-mechanism for herbal medicine along with its active components in treating rheumatoid arthritis. Biomolecules (2019) 9(12):795. doi: 10.3390/biom9120795</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9120795</ArticleId><ArticleId IdType="pmc">PMC6995542</ArticleId><ArticleId IdType="pubmed">31795133</ArticleId></ArticleIdList></Reference><Reference><Citation>Na H-J, Lee S-J, Kang Y-C, Cho Y-L, Nam W-D, Kim PK, et al. . Inhibition of farnesyltransferase prevents collagen-induced arthritis by down-regulation of inflammatory gene expression through suppression of p21ras-dependent NF-&#x3ba;B activation. J Immunol (2004) 173(2):1276&#x2013;83. doi: 10.4049/jimmunol.173.2.1276</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.2.1276</ArticleId><ArticleId IdType="pubmed">15240720</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips MR, Cox AD. Geranylgeranyltransferase I as a target for anti-cancer drugs. J Clin Invest (2007) 117(5):1223&#x2013;5. doi: 10.1172/JCI32108</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI32108</ArticleId><ArticleId IdType="pmc">PMC1857249</ArticleId><ArticleId IdType="pubmed">17476354</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffen U, Schett G, Bozec A. How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis. Front Immunol (2019) 10:1483. doi: 10.3389/fimmu.2019.01483</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01483</ArticleId><ArticleId IdType="pmc">PMC6619397</ArticleId><ArticleId IdType="pubmed">31333647</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoughi M, Saravani M, Rokni M, Nora M, Mehrabani M, Dehghan A. Association between COX-2 and 15-PGDH polymorphisms and SLE susceptibility. Int J Rheumatic Dis (2020) 23(5):627&#x2013;32. doi: 10.1111/1756-185X.13808</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13808</ArticleId><ArticleId IdType="pubmed">32100450</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashi E, Wang Y, Diamond B. The role of b cells in lupus pathogenesis. Int J Biochem Cell Biol (2010) 42(4):543&#x2013;50. doi: 10.1016/j.biocel.2009.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2009.10.011</ArticleId><ArticleId IdType="pmc">PMC2835836</ArticleId><ArticleId IdType="pubmed">19850148</ArticleId></ArticleIdList></Reference><Reference><Citation>Choileain NN, Redmond H. Regulatory T-cells and autoimmunity. J Surg Res (2006) 130(1):124&#x2013;35. doi: 10.1016/j.jss.2005.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2005.07.033</ArticleId><ArticleId IdType="pubmed">16154142</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco P, Viallard J-F, Pellegrin J-L, Moreau J-F. Cytotoxic T lymphocytes and autoimmunity. Curr Opin Rheumatol (2005) 17(6):731&#x2013;4. doi: 10.1097/01.bor.0000179942.27777.f8</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.bor.0000179942.27777.f8</ArticleId><ArticleId IdType="pubmed">16224251</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Chess L. Regulation of immune responses by T cells. N Engl J Med (2006) 354(11):1166&#x2013;76. doi: 10.1056/NEJMra055446</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra055446</ArticleId><ArticleId IdType="pubmed">16540617</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cava A, Fang CJ, Singh RP, Ebling F, Hahn BH. Manipulation of immune regulation in systemic lupus erythematosus. Autoimmun Rev (2005) 4(8):515&#x2013;9. doi: 10.1016/j.autrev.2005.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2005.04.008</ArticleId><ArticleId IdType="pubmed">16214088</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap DYH, Chan TM. B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci (2019) 20(24):6231. doi: 10.3390/ijms20246231</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246231</ArticleId><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>Karrar S, Cunninghame Graham DS. Abnormal b cell development in systemic lupus erythematosus: what the genetics tell us. Arthritis Rheumatol (Hoboken NJ) (2018) 70(4):496&#x2013;507. doi: 10.1002/art.40396</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40396</ArticleId><ArticleId IdType="pmc">PMC5900717</ArticleId><ArticleId IdType="pubmed">29207444</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapoport M, Mor A, Amit M, Rosenberg R, Ramot Y, Mizrachi A, et al. . Decreased expression of the p21ras stimulatory factor hSOS in PBMC from inactive SLE patients. Lupus (1999) 8(1):24&#x2013;8. doi: 10.1191/096120399678847362</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120399678847362</ArticleId><ArticleId IdType="pubmed">10025596</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapoport MJ, Amit M, Aharoni D, Weiss M, Weissgarten J, Bruck N, et al. . Constitutive up-regulated activity of MAP kinase is associated with down-regulated early p21Ras pathway in lymphocytes of SLE patients. J Autoimmun (2002) 19(1-2):63&#x2013;70. doi: 10.1006/jaut.2002.0596</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.2002.0596</ArticleId><ArticleId IdType="pubmed">12367560</ArticleId></ArticleIdList></Reference><Reference><Citation>Cede&#xf1;o S, Cifarelli DF, Blasini AM, Paris M, Placeres F, Alonso G, et al. . Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: potential role of altered coupling of ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clin Immunol (2003) 106(1):41&#x2013;9. doi: 10.1016/S1521-6616(02)00052-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1521-6616(02)00052-9</ArticleId><ArticleId IdType="pubmed">12584050</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YF, Morel L. Genetics of T cell defects in lupus. Cell Mol Immunol (2005) 2(6):403&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16426489</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol (2006) 239(2):121&#x2013;8. doi: 10.1016/j.cellimm.2006.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2006.05.003</ArticleId><ArticleId IdType="pubmed">16808908</ArticleId></ArticleIdList></Reference><Reference><Citation>Marti F, Garcia GG, Lapinski PE, MacGregor JN, King PD. Essential role of the T cell&#x2013;specific adapter protein in the activation of LCK in peripheral T cells. J Exp Med (2006) 203(2):281&#x2013;7. doi: 10.1084/jem.20051637</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20051637</ArticleId><ArticleId IdType="pmc">PMC2118198</ArticleId><ArticleId IdType="pubmed">16446380</ArticleId></ArticleIdList></Reference><Reference><Citation>Norment AM, Bogatzki LY, Klinger M, Ojala EW, Bevan MJ, Kay RJ. Transgenic expression of RasGRP1 induces the maturation of double-negative thymocytes and enhances the production of CD8 single-positive thymocytes. J Immunol (2003) 170(3):1141&#x2013;9. doi: 10.4049/jimmunol.170.3.1141</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.3.1141</ArticleId><ArticleId IdType="pubmed">12538669</ArticleId></ArticleIdList></Reference><Reference><Citation>An X-J, Xia Y, Li J, Dong L-Y, Wang Y-J, Yang J, et al. . RasGRP3 in peripheral blood mononuclear cells is associated with disease activity and implicated in the development of systemic lupus erythematosus. Am J Trans Res (2019) 11(3):1800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456560</ArticleId><ArticleId IdType="pubmed">30972203</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman SP, Yang J, Thomas RM, Wells AD, Turka LA. Defective activation of protein kinase c and ras-ERK pathways limits IL-2 production and proliferation by CD4+ CD25+ regulatory T cells. J Immunol (2006) 177(4):2186&#x2013;94. doi: 10.4049/jimmunol.177.4.2186</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.4.2186</ArticleId><ArticleId IdType="pubmed">16887978</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>